Zoetis Inc. (NYSE:ZTS) Shares Sold by Apollon Wealth Management LLC

Apollon Wealth Management LLC lessened its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 33.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,274 shares of the company’s stock after selling 5,687 shares during the period. Apollon Wealth Management LLC’s holdings in Zoetis were worth $1,837,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ZTS. Darwin Wealth Management LLC purchased a new position in shares of Zoetis in the 3rd quarter valued at about $31,000. First Personal Financial Services acquired a new position in Zoetis during the third quarter worth about $33,000. Capital Performance Advisors LLP purchased a new position in Zoetis in the third quarter valued at about $33,000. Dunhill Financial LLC lifted its position in shares of Zoetis by 80.6% during the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares during the period. Finally, Fortitude Family Office LLC boosted its stake in shares of Zoetis by 1,387.5% during the 3rd quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock worth $46,000 after acquiring an additional 222 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Zoetis Stock Down 1.6 %

Shares of NYSE ZTS opened at $171.37 on Monday. The firm’s 50 day moving average price is $169.26 and its 200 day moving average price is $179.22. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The firm has a market cap of $77.32 billion, a P/E ratio of 32.21, a price-to-earnings-growth ratio of 2.77 and a beta of 0.90. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.53.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be paid a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.17%. Zoetis’s payout ratio is currently 37.59%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. UBS Group began coverage on Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus cut their price target on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Leerink Partners assumed coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective on the stock. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Finally, Morgan Stanley lowered their price target on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 29th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $215.00.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.